The Union Health Ministry has approved the introduction of a new treatment regimen for drug-resistant tuberculosis in India. The BPaLM regimen consisting of four drugs — Bedaquiline, Pretomanid, Linezolid and Moxifloxacin — has proven to be a safe, more effective and quicker treatment option than the previous Multidrug-Resistant Tuberculosis treatment procedure, the Ministry said on Friday. While traditional treatments can …
Mumbai: There’s some cheer in store for drug-resistant tuberculosis patients, who have been abiding a prolonged treatment regimen with severe side-effects. HT Image The present treatment guideline, which has 13 to 14 drugs given daily for a period of 18 to 24 months, was formulated two and a half years ago. The core committee of the National TB Elimination Programme …
